[Stock Spotlight] Hanmi Pharm Gains Over 3% as Domestically Developed Obesity Drug 'Efpeglenatide' Begins Prescriptions
Predicted impact: Low
Obesity drug prescription start already reported in the last 14 days.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.